Cancer mortality and atenolol treatment.
Fletcher
A E
AE
Division of Geriatric Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Beevers
D G
DG
Bulpitt
C J
CJ
Coles
E C
EC
Dollery
C T
CT
Ledingham
J G
JG
Palmer
A J
AJ
Petrie
J C
JC
Webster
J
J
D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D004739:England / Q000453:epidemiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality*; D012307:Risk Factors
D001262:Atenolol